Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95432 | 1.00 | MAOB (0.68) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL96922 | 0.90 | MAOB (0.70) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL96921 | 0.90 | MAOB (0.70) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL27571915 | 0.87 | MAOB (0.67) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL23458007 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL592744 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL5875512 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL6853572 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| Benzene SCHEMBL9803304 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| Benzene SCHEMBL135524 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114920636-B | Synthesis method of alpha chloro-aryl-ethanone compound | 东南大学 | 2023-12-22 | — | — | CN | claimed |
| CN-113831272-B | Method for synthesizing 2-substituted indole compound by palladium-catalyzed iodobenzene and oxime ester | 华南理工大学 | 2023-07-18 | — | — | CN | claimed |
| CN-114920636-A | Synthetic method of alpha chloro arylethanone compound | 东南大学 | 2022-08-19 | — | — | CN | claimed |
| CN-113831272-A | Method for synthesizing 2-substituted indole compound by using palladium to catalyze iodobenzene and oxime ester | 华南理工大学 | 2021-12-24 | — | — | CN | claimed |
| CN-112534356-A | Electrophotographic photoreceptor, method for producing the same, and electrophotographic apparatus | 富士电机株式会社 | 2021-03-19 | — | — | CN | claimed |
| EP-0885192-B8 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) | 2012-05-16 | — | — | EP | claimed |
| EP-2311806-A2 | Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists | The United States of America, Represented by the Secretary, Department of Health and Human Services (US) | 2011-04-20 | — | — | EP | claimed |
| US-20070092551-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-04-26 | — | — | US | claimed |
| EP-1623704-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-08 | — | — | EP | claimed |
| EP-0670041-B1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INC (US) | 2002-01-30 | — | — | EP | claimed |
| EP-0264198-A2 | Optical information recording medium | CANON KABUSHIKI KAISHA (JP) | 1988-04-20 | — | — | EP | claimed |
| US-4738908-A | AQULENIUM SALT | CANON KABUSHIKI KAISHA (JP) | 1988-04-19 | — | — | US | claimed |
| US-4673630-A | Photoconductive film and electrophotographic photosensitive member contains azulenium salt | CANON KABUSHIKI KAISHA (JP) | 1987-06-16 | — | — | US | claimed |
| US-4629670-A | INFRARED RADIATION SENSITIVITY | CANON KABUSHIKI KAISHA (JP) | 1986-12-16 | — | — | US | claimed |
| US-4548886-A | ELECTROGRAPHIC FILMS; OPTICAL RECORDING MEDIA | CANON KABUSHIKI KAISHA (JP) | 1985-10-22 | — | — | US | claimed |
| EP-0139614-A2 | Pharmaceutical preparations containing flavanone or thioflavanone derivatives, the use thereof, novel flavanones and thioflavanones, and processes for their manufacture | Zyma SA (CH) | 1985-05-02 | — | — | EP | claimed |
| US-4206142-A | REACTING A STYRYLSULFONYLAMIDINE WITH A BASE | MEAD JOHNSON & COMPANY (US) | 1980-06-03 | — | — | US | claimed |
| US-4130663-A | ANTITHROMBOGENIC, ANTIHYPERTENSIVE | MEAD JOHNSON & COMPANY (US) | 1978-12-19 | — | — | US | claimed |
| US-4096183-A | Styrylsulfonylamidines | MEAD JOHNSON & COMPANY (US) | 1978-06-20 | — | — | US | claimed |
| US-4052455-A | ANALGESICS, BLOOD PLATELET AGGREGATION INHIBITORS | MEAD JOHNSON & COMPANY (US) | 1977-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092551-A1 | Therapeutic agent | FABP4, GPR119, IAPP | MAOB 4382/4885MAPK1 1311/4885ALDH1A1 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.